Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
265.57M | 262.08M | 251.43M | 223.93M | 165.09M | 195.79M | Gross Profit |
32.97M | 31.70M | 31.45M | 29.92M | 20.92M | 23.33M | EBIT |
1.94M | 1.18M | 4.50M | 5.17M | -206.00K | 944.00K | EBITDA |
3.65M | 3.86M | 6.92M | 7.54M | 4.55M | 3.16M | Net Income Common Stockholders |
-1.08M | -1.20M | 2.52M | 3.00M | 1.41M | -252.00K |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
2.08M | 438.00K | 4.23M | 2.76M | 5.74M | 1.48M | Total Assets |
103.03M | 99.54M | 100.03M | 84.49M | 94.82M | 96.28M | Total Debt |
16.70M | 35.80M | 33.58M | 27.23M | 39.25M | 45.11M | Net Debt |
14.63M | 35.36M | 29.35M | 24.47M | 33.51M | 43.63M | Total Liabilities |
72.98M | 70.81M | 68.37M | 49.76M | 67.23M | 69.89M | Stockholders Equity |
30.04M | 28.74M | 31.66M | 34.73M | 27.59M | 26.38M |
Cash Flow | Free Cash Flow | ||||
-1.46M | -2.46M | 3.33M | 553.00K | 6.33M | -1.78M | Operating Cash Flow |
-159.00K | 119.00K | 4.24M | 3.39M | 6.72M | -802.00K | Investing Cash Flow |
-1.06M | -2.33M | -716.00K | -2.65M | -209.00K | -795.00K | Financing Cash Flow |
560.00K | -1.57M | -2.05M | -3.71M | -2.26M | -833.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | £184.22M | 11.83 | 13.06% | 2.34% | -3.66% | 3.28% | |
76 Outperform | £2.52B | 6.59 | 18.69% | 6.66% | -19.08% | 57.32% | |
70 Outperform | £197.95M | 11.42 | 5.09% | 2.85% | 7.94% | -25.81% | |
67 Neutral | £260.96M | 5.90 | 10.69% | ― | 0.50% | ― | |
62 Neutral | $6.88B | 11.07 | 2.77% | 4.28% | 2.67% | -24.94% | |
55 Neutral | £141.29M | 45.90 | 11.03% | ― | -17.31% | 47.33% | |
39 Underperform | £12.27M | 69.77 | 0.60% | 2.22% | -0.42% | -183.34% |